Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Inflammation
Published in: Inflammation 2/2002

01-04-2002

Muscle Proteolysis and Weight Loss in a Neonatal Rat Model of Sepsis Syndrome

Authors: D. M. Premer, R. Goertz, M. K. Georgieff, M. C. Mammel, S. J. Schwarzenberg

Published in: Inflammation | Issue 2/2002

Login to get access
Metadata
Title
Muscle Proteolysis and Weight Loss in a Neonatal Rat Model of Sepsis Syndrome
Authors
D. M. Premer
R. Goertz
M. K. Georgieff
M. C. Mammel
S. J. Schwarzenberg
Publication date
01-04-2002
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Inflammation / Issue 2/2002
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1023/A:1014840412552

Other articles of this Issue 2/2002

Inflammation 2/2002 Go to the issue

OriginalPaper

Effects of Allergina on the Treatment of Otitis Media with Effusions

OriginalPaper

Inhibition of IL-8–Mediated MAPK Activation in Human Neutrophils by β1 Integrin Ligands

OriginalPaper

Early Vascular Permeability in Murine Experimental Peritonitis Is Comediated by Resident Peritoneal Macrophages and Mast Cells: Crucial Involvement of Macrophage-Derived Cysteinyl-Leukotrienes

OriginalPaper

Inflammatory Cytokines Mediate C–C (Monocyte Chemotactic Protein 1) and C–X–C (Interleukin 8) Chemokine Expression in Human Pleural Fibroblasts

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits